Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353184 · ClinicalTrials.gov registry record · NA
Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00353184 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 27 participants.
The verdict
NCT00353184, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Oral montelukast is helpful in chronic asthma. The purpose of this pediatric study was to investigate whether the addition of oral montelukast to standard therapy for acute asthma exacerbations results in further improvement in breathing function over three hours.
Interventions
- DRUG Montelukast 5-mg orally added to standard therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2001-09 |
| Est. Completion | 2005-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00353184
The ClinicalTrials.gov registry entry for NCT00353184 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Montelukast 5-mg orally added to standard therapy is the first listed.
NCT00353184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00353184 about?
NCT00353184 is a clinical study titled "Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years". Oral montelukast is helpful in chronic asthma. The purpose of this pediatric study was to investigate whether the addition of oral montelukast to standard therapy for acute asthma exacerbations results in further improvement in breathing function over three hours.
What is the current status of trial NCT00353184?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2001-09. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00353184?
The interventions under investigation include: Montelukast 5-mg orally added to standard therapy (DRUG).
Who is sponsoring clinical trial NCT00353184?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.